BCL9 (B cell CLL/lymphoma 9), a component of Wnt/β‐catenin pathway, can form a complex with β‐catenin and activate Wnt/β‐catenin targeted‐genes to promote tumor development.19, 20. This evidence concerns the gene BCL9 and neoplasm.